Abstract
Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with heart failure. It may occur in patients who have hypovolemic, hypervolemic, or euvolemic state. It is usually not corrected by available therapies. It is a major predictor of prognosis, and correction of hyponatremia can be effectively accomplished by vasopressin antagonists. However, it still remains to be seen whether the normalization of serum sodium with vasopressin antagonists will also lead to an improved long-term prognosis.
Original language | English (US) |
---|---|
Pages (from-to) | 59-63 |
Number of pages | 5 |
Journal | Heart Failure Reviews |
Volume | 14 |
Issue number | 2 |
DOIs | |
State | Published - 2009 |
Keywords
- Conivaptan
- Heart failure
- Hyponatremia
- Lixivaptan
- Tolvaptan
- Vasopressin
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine